Fischer Medical Ventures Limited — Disclosure of material issue

Fischer Medical Ventures Limited has announced the appointment of Mr. Chan Sing En as an Independent Director on the board of its wholly owned subsidiary, FMV Global Innovations Pte. Ltd. This appointment is effective from today, October 27, 2026. The subsidiary is a material entity within the company's structure and is currently unlisted.

For investors, this development signals a strengthening of governance and oversight at a key operational unit. The addition of an independent director is generally viewed as a positive step, as it helps bring in external expertise and ensures more objective decision-making within the subsidiary.

Investors should watch for any further updates regarding the subsidiary's future plans or its eventual listing, as these could impact the parent company's valuation and operational strategy.